BlackRock Health Sciences Trust II
WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
09260E105
SEDOL
N/A
CIK
0001785971
www.blackrock.com
LEI:
549300FGMK4EGHSK8N86
New:
Infographics
X-Lab
FIGI: BBG00R28MS68
BMEZ
BlackRock Health Sciences Trust II
GICS: -
·
Sektor: ETF
·
Sub-Sektor: Investment Trusts/Mutual Funds
NAME
BlackRock Health Sciences Trust II
ISIN
US09260E1055
TICKER
BMEZ
MIC
XNYS
REUTERS
BMEZ.N
BLOOMBERG
BMEZ US
F&G:
35
Financial Intelligence
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Di., 22.04.2025
BlackRock Health Sciences
US09260E1055
BlackRock Health Sciences Term Trust (the “Fund”) announced today the final results of the Fund’s tender offer (the “Tender Offer”) for up to 40% of its outstanding common shares (the “Shares”), which expired on April 17, 2025.
The Tender Offer was undersubscribed. Therefore, in accordance with the terms and conditions of the Tender Offer, the Fu...
BlackRock Health Sciences
Fr., 18.04.2025
BlackRock Health Sciences
US09260E1055
BlackRock Health Sciences Term Trust (the “Fund”) announced today the expiration and preliminary results of the Fund’s tender offer (the “Tender Offer”) for up to 40% of its outstanding common shares (the “Shares”).
The Tender Offer commenced on March 21, 2025 and expired at 5:00 p.m. Eastern time on April 17, 2025.
Based on preliminary informat...
BlackRock Health Sciences
Fr., 21.03.2025
BlackRock Health Sciences
US09260E1055
BlackRock Health Sciences Term Trust (NYSE: BMEZ) announced today the commencement, expiration and pricing dates of the previously announced offer to repurchase up to 40% of outstanding common shares at a price per share equal to 99.5% of the Fund’s net asset value per common share as determined on the pricing date (the “Tender Offer”).
The Fund’...
BlackRock Health Sciences
Di., 21.01.2025
BlackRock Health Sciences
US09260E1055
BlackRock Advisors, LLC (“BlackRock”) announced today that the Board of Trustees of BlackRock Innovation and Growth Term Trust (NYSE: BIGZ) has approved a tender offer to repurchase 50% of BIGZ’s outstanding shares, and that the Board of Trustees of BlackRock Health Sciences Term Trust (NYSE: BMEZ) has approved a tender offer to repurchase 40% of ...
BlackRock Health Sciences
Di., 21.01.2025
BlackRock Health Sciences
US09260E1055
Saba Capital Management, L.P. (together with certain of its affiliates, “Saba”) today announced that it has entered into standstill agreements (the “Agreements”) with BlackRock Advisors, LLC, which is the investment advisor of the BlackRock Innovation and Growth Term Trust (NYSE: BIGZ) and the BlackRock Health Sciences Term Trust (NYSE: BMEZ) (the...
BlackRock Health Sciences
Fr., 06.12.2024
BlackRock Health Sciences
US09260E1055
Certain BlackRock closed-end funds (the “Funds”) announced distributions today as detailed below.
Municipal Funds:
Declaration- 12/6/2024 Ex-Date- 12/16/2024 Record- 12/16/2024 Payable- 12/31/2024
National Funds
Ticker
Distribution
Change From Prior Distribution
BlackRock Municipal Income Quality Trust*
...
BlackRock Health Sciences
Mi., 20.11.2024
BlackRock Health Sciences
US09260E1055
The BlackRock closed-end funds (the “Funds”) listed below announced today the final results of each Fund’s tender offer (each, a “Tender Offer”) for up to 2.5% of its outstanding common shares (the “Shares”).
The Tender Offers, which expired at 5:00 p.m. Eastern time on November 18, 2024, were oversubscribed for each Fund.
Therefore, in accord...
BlackRock Health Sciences
Mi., 21.08.2024
BlackRock Health Sciences
US09260E1055
The BlackRock closed-end funds (the “Funds”) listed below announced today the final results of each Fund’s tender offer (each, a “Tender Offer”) for up to 2.5% of its outstanding common shares (the “Shares”).
The Tender Offers, which expired at 5:00 p.m. Eastern time on August 19, 2024, were oversubscribed for each Fund.
Therefore, in accordan...
BlackRock Health Sciences
Di., 20.08.2024
BlackRock Health Sciences
US09260E1055
The BlackRock closed-end funds (the “Funds”) listed below announced today the expiration and preliminary results of each Fund’s tender offer (each, a “Tender Offer”) for up to 2.5% of its outstanding common shares (the “Shares”).
Each Tender Offer commenced on July 18, 2024 and expired at 5:00 p.m. Eastern time on August 19, 2024.
Based on pre...
BlackRock Health Sciences
Informationen zu Product Placements
SMART * AD
P R O D U C T S U G G E S T I O N S
